204 related articles for article (PubMed ID: 35153801)
1. Towards Structure-Guided Development of Pain Therapeutics Targeting Voltage-Gated Sodium Channels.
Nguyen PT; Yarov-Yarovoy V
Front Pharmacol; 2022; 13():842032. PubMed ID: 35153801
[TBL] [Abstract][Full Text] [Related]
2. Engineering of highly potent and selective HNTX-III mutant against hNa
Zhang Y; Wang L; Peng D; Zhang Q; Yang Q; Li J; Li D; Tang D; Chen M; Liang S; Liu Y; Wang S; Liu Z
J Biol Chem; 2021; 296():100326. PubMed ID: 33493520
[TBL] [Abstract][Full Text] [Related]
3. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of μ-conotoxin KIIIA interaction with the human voltage-gated sodium channel Na
Kimball IH; Nguyen PT; Olivera BM; Sack JT; Yarov-Yarovoy V
Front Pharmacol; 2023; 14():1156855. PubMed ID: 37007002
[TBL] [Abstract][Full Text] [Related]
5. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
[TBL] [Abstract][Full Text] [Related]
6. Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.
McCormack K; Santos S; Chapman ML; Krafte DS; Marron BE; West CW; Krambis MJ; Antonio BM; Zellmer SG; Printzenhoff D; Padilla KM; Lin Z; Wagoner PK; Swain NA; Stupple PA; de Groot M; Butt RP; Castle NA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):E2724-32. PubMed ID: 23818614
[TBL] [
